Millrace Asset Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,434
Closed -$287K 81
2023
Q3
$287K Buy
+15,434
New +$360K 0.35% 56
2023
Q2
Sell
-36,298
Closed -$940K 63
2023
Q1
$940K Buy
+36,298
New +$971K 1.1% 44
2019
Q2
Sell
-28,118
Closed -$1.56M 75
2019
Q1
$1.56M Buy
28,118
+10,092
+56% +$616K 1.32% 43
2018
Q4
$894K Buy
18,026
+3,500
+24% +$214K 0.82% 52
2018
Q3
$1.25M Sell
14,526
-9,000
-38% -$641K 0.98% 53
2018
Q2
$1.37M Sell
23,526
-13,492
-36% -$659K 1.04% 54
2018
Q1
$1.49M Buy
+37,018
New +$1.4M 1.45% 34

Other funds holding TDOC

Millrace Asset Group's TDOC Position: Q4 2023 in Review

Millrace Asset Group sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 15,434 shares — an estimated $287K sold.

Millrace Asset Group first reported a position in TDOC in Q1 2018 and held it in 7 quarters. The position peaked at $1.56M in Q1 2019. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • Millrace Asset Group reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
  • Millrace Asset Group sold 15,434 Teladoc Health shares in Q4 2023, an estimated $287K.
  • Millrace Asset Group first reported a position in Teladoc Health in Q1 2018 and held it in 7 quarters.
  • Millrace Asset Group's Teladoc Health position peaked at $1.56M in Q1 2019.
  • 435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Millrace Asset Group's 13F filing for Q4 2023, filed 12 Feb 2024.